nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—ALB—chronic obstructive pulmonary disease	0.725	1	CbGaD
Ethacrynic acid—Pancreatitis acute—Roflumilast—chronic obstructive pulmonary disease	0.0123	0.0744	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion transport by P-type ATPases—ATP2C2—chronic obstructive pulmonary disease	0.0116	0.115	CbGpPWpGaD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—GCLC—chronic obstructive pulmonary disease	0.00765	0.0758	CbGpPWpGaD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—HMOX1—chronic obstructive pulmonary disease	0.00529	0.0524	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTT1—chronic obstructive pulmonary disease	0.00422	0.0418	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GCLC—chronic obstructive pulmonary disease	0.00418	0.0413	CbGpPWpGaD
Ethacrynic acid—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.00408	0.0247	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00402	0.0398	CbGpPWpGaD
Ethacrynic acid—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.00386	0.0233	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00358	0.0355	CbGpPWpGaD
Ethacrynic acid—Gout—Formoterol—chronic obstructive pulmonary disease	0.00309	0.0187	CcSEcCtD
Ethacrynic acid—Gout—Arformoterol—chronic obstructive pulmonary disease	0.00309	0.0187	CcSEcCtD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTP1—chronic obstructive pulmonary disease	0.00293	0.029	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTM1—chronic obstructive pulmonary disease	0.00269	0.0266	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00263	0.026	CbGpPWpGaD
Ethacrynic acid—Pancreatitis acute—Prednisone—chronic obstructive pulmonary disease	0.00246	0.0149	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0023	0.0139	CcSEcCtD
Ethacrynic acid—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00224	0.0136	CcSEcCtD
Ethacrynic acid—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.0135	CcSEcCtD
Ethacrynic acid—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00223	0.0135	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00214	0.013	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.013	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00214	0.013	CcSEcCtD
Ethacrynic acid—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.0127	CcSEcCtD
Ethacrynic acid—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00209	0.0126	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.0122	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.0122	CcSEcCtD
Ethacrynic acid—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.0122	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00191	0.0189	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.0019	0.0188	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00188	0.0186	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00186	0.0184	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00176	0.0107	CcSEcCtD
Ethacrynic acid—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00175	0.0106	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.0101	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00987	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00987	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00156	0.0155	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00154	0.0153	CbGpPWpGaD
Ethacrynic acid—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00932	CcSEcCtD
Ethacrynic acid—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00931	CcSEcCtD
Ethacrynic acid—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00154	0.0093	CcSEcCtD
Ethacrynic acid—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.0093	CcSEcCtD
Ethacrynic acid—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00898	CcSEcCtD
Ethacrynic acid—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.0089	CcSEcCtD
Ethacrynic acid—GSTA2—respiratory system—chronic obstructive pulmonary disease	0.00147	0.174	CbGeAlD
Ethacrynic acid—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00879	CcSEcCtD
Ethacrynic acid—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00878	CcSEcCtD
Ethacrynic acid—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00868	CcSEcCtD
Ethacrynic acid—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.0085	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0014	0.0139	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00839	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00137	0.0136	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00136	0.0134	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.0013	0.0129	CbGpPWpGaD
Ethacrynic acid—GSTA2—connective tissue—chronic obstructive pulmonary disease	0.0013	0.153	CbGeAlD
Ethacrynic acid—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00779	CcSEcCtD
Ethacrynic acid—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00779	CcSEcCtD
Ethacrynic acid—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00773	CcSEcCtD
Ethacrynic acid—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00772	CcSEcCtD
Ethacrynic acid—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00771	CcSEcCtD
Ethacrynic acid—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00768	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00125	0.0124	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00124	0.0123	CbGpPWpGaD
Ethacrynic acid—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00742	CcSEcCtD
Ethacrynic acid—GSTA2—bronchus—chronic obstructive pulmonary disease	0.00121	0.143	CbGeAlD
Ethacrynic acid—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00728	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.0012	0.0119	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00118	0.0116	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.0071	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00707	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00707	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00115	0.0114	CbGpPWpGaD
Ethacrynic acid—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00687	CcSEcCtD
Ethacrynic acid—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00687	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00668	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0011	0.0109	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00109	0.0108	CbGpPWpGaD
Ethacrynic acid—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00649	CcSEcCtD
Ethacrynic acid—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00647	CcSEcCtD
Ethacrynic acid—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00647	CcSEcCtD
Ethacrynic acid—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00647	CcSEcCtD
Ethacrynic acid—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00647	CcSEcCtD
Ethacrynic acid—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00646	CcSEcCtD
Ethacrynic acid—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00641	CcSEcCtD
Ethacrynic acid—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00641	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.00106	0.0105	CbGpPWpGaD
Ethacrynic acid—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00633	CcSEcCtD
Ethacrynic acid—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00611	CcSEcCtD
Ethacrynic acid—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00605	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000987	0.00597	CcSEcCtD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000959	0.0095	CbGpPWpGaD
Ethacrynic acid—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000926	0.0056	CcSEcCtD
Ethacrynic acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000925	0.00559	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000914	0.00905	CbGpPWpGaD
Ethacrynic acid—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000887	0.00536	CcSEcCtD
Ethacrynic acid—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000887	0.00536	CcSEcCtD
Ethacrynic acid—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00088	0.00532	CcSEcCtD
Ethacrynic acid—Pain—Formoterol—chronic obstructive pulmonary disease	0.00088	0.00532	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000869	0.00861	CbGpPWpGaD
Ethacrynic acid—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000869	0.00525	CcSEcCtD
Ethacrynic acid—Pain—Montelukast—chronic obstructive pulmonary disease	0.000862	0.00521	CcSEcCtD
Ethacrynic acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000859	0.0052	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000857	0.00849	CbGpPWpGaD
Ethacrynic acid—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.00515	CcSEcCtD
Ethacrynic acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000851	0.00515	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.00513	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000848	0.00513	CcSEcCtD
Ethacrynic acid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00512	CcSEcCtD
Ethacrynic acid—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000844	0.00511	CcSEcCtD
Ethacrynic acid—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000837	0.00506	CcSEcCtD
Ethacrynic acid—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000831	0.00502	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000824	0.00498	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.00082	0.00812	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000813	0.00492	CcSEcCtD
Ethacrynic acid—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000813	0.00492	CcSEcCtD
Ethacrynic acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00081	0.0049	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000804	0.00796	CbGpPWpGaD
Ethacrynic acid—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000804	0.00486	CcSEcCtD
Ethacrynic acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000803	0.00486	CcSEcCtD
Ethacrynic acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000803	0.00485	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.00484	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000799	0.00791	CbGpPWpGaD
Ethacrynic acid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.00483	CcSEcCtD
Ethacrynic acid—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000797	0.00482	CcSEcCtD
Ethacrynic acid—GSTA2—lung—chronic obstructive pulmonary disease	0.000781	0.0921	CbGeAlD
Ethacrynic acid—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00078	0.00773	CbGpPWpGaD
Ethacrynic acid—ATP1A1—respiratory system—chronic obstructive pulmonary disease	0.000779	0.0919	CbGeAlD
Ethacrynic acid—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000768	0.00464	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000766	0.00758	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000762	0.00755	CbGpPWpGaD
Ethacrynic acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000757	0.00458	CcSEcCtD
Ethacrynic acid—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00446	CcSEcCtD
Ethacrynic acid—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00446	CcSEcCtD
Ethacrynic acid—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000723	0.00437	CcSEcCtD
Ethacrynic acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000704	0.00426	CcSEcCtD
Ethacrynic acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000704	0.00426	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000701	0.00694	CbGpPWpGaD
Ethacrynic acid—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00421	CcSEcCtD
Ethacrynic acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00417	CcSEcCtD
Ethacrynic acid—ATP1A1—connective tissue—chronic obstructive pulmonary disease	0.000686	0.0809	CbGeAlD
Ethacrynic acid—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000666	0.00403	CcSEcCtD
Ethacrynic acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00402	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000664	0.00658	CbGpPWpGaD
Ethacrynic acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000654	0.00396	CcSEcCtD
Ethacrynic acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000654	0.00396	CcSEcCtD
Ethacrynic acid—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00392	CcSEcCtD
Ethacrynic acid—Rash—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00392	CcSEcCtD
Ethacrynic acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00392	CcSEcCtD
Ethacrynic acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00392	CcSEcCtD
Ethacrynic acid—Headache—Formoterol—chronic obstructive pulmonary disease	0.000644	0.0039	CcSEcCtD
Ethacrynic acid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.0039	CcSEcCtD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000644	0.00638	CbGpPWpGaD
Ethacrynic acid—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000643	0.00389	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00388	CcSEcCtD
Ethacrynic acid—ATP1A1—bronchus—chronic obstructive pulmonary disease	0.000641	0.0756	CbGeAlD
Ethacrynic acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000641	0.00387	CcSEcCtD
Ethacrynic acid—Rash—Montelukast—chronic obstructive pulmonary disease	0.000635	0.00384	CcSEcCtD
Ethacrynic acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000635	0.00384	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000633	0.00383	CcSEcCtD
Ethacrynic acid—Headache—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00382	CcSEcCtD
Ethacrynic acid—ATP1A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000627	0.074	CbGeAlD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00062	0.00614	CbGpPWpGaD
Ethacrynic acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.00373	CcSEcCtD
Ethacrynic acid—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000616	0.00372	CcSEcCtD
Ethacrynic acid—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000613	0.00371	CcSEcCtD
Ethacrynic acid—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.0037	CcSEcCtD
Ethacrynic acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.0037	CcSEcCtD
Ethacrynic acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000611	0.00369	CcSEcCtD
Ethacrynic acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.00369	CcSEcCtD
Ethacrynic acid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00368	CcSEcCtD
Ethacrynic acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000598	0.00362	CcSEcCtD
Ethacrynic acid—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000591	0.00358	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000585	0.0058	CbGpPWpGaD
Ethacrynic acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00349	CcSEcCtD
Ethacrynic acid—ATP1A1—trachea—chronic obstructive pulmonary disease	0.000576	0.0679	CbGeAlD
Ethacrynic acid—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000574	0.00347	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000534	0.00529	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000524	0.00519	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000522	0.00517	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000477	0.00472	CbGpPWpGaD
Ethacrynic acid—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.00288	CcSEcCtD
Ethacrynic acid—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000467	0.00283	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00278	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.00278	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000454	0.0045	CbGpPWpGaD
Ethacrynic acid—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000447	0.0027	CcSEcCtD
Ethacrynic acid—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000446	0.00269	CcSEcCtD
Ethacrynic acid—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00043	0.0026	CcSEcCtD
Ethacrynic acid—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000421	0.00254	CcSEcCtD
Ethacrynic acid—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00252	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000416	0.00412	CbGpPWpGaD
Ethacrynic acid—ATP1A1—lung—chronic obstructive pulmonary disease	0.000414	0.0488	CbGeAlD
Ethacrynic acid—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000413	0.00409	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000394	0.0039	CbGpPWpGaD
Ethacrynic acid—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00233	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000368	0.00365	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000357	0.00354	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000354	0.00351	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000352	0.00213	CcSEcCtD
Ethacrynic acid—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00212	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00212	CcSEcCtD
Ethacrynic acid—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00211	CcSEcCtD
Ethacrynic acid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00211	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GC—chronic obstructive pulmonary disease	0.000344	0.00341	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000339	0.00335	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00202	CcSEcCtD
Ethacrynic acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.002	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000326	0.00322	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00032	0.00317	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00194	CcSEcCtD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000304	0.00301	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000302	0.00299	CbGpPWpGaD
Ethacrynic acid—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00176	CcSEcCtD
Ethacrynic acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000277	0.00167	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000276	0.00273	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000275	0.00272	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000271	0.00269	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00026	0.00258	CbGpPWpGaD
Ethacrynic acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00156	CcSEcCtD
Ethacrynic acid—Rash—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00154	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00154	CcSEcCtD
Ethacrynic acid—Headache—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00153	CcSEcCtD
Ethacrynic acid—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00145	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000219	0.00217	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000217	0.00215	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000212	0.0021	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000211	0.00209	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000211	0.00209	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00019	0.00188	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000188	0.00186	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000186	0.00184	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000183	0.00182	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000182	0.0018	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000181	0.0018	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000173	0.00171	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000172	0.0017	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00017	0.00168	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000168	0.00166	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000168	0.00166	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000165	0.00163	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00155	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000153	0.00152	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000137	0.00135	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000136	0.00134	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00013	0.00129	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000129	0.00127	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000125	0.00124	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000125	0.00124	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000124	0.00123	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00119	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000119	0.00118	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000116	0.00115	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000115	0.00114	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000115	0.00113	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00112	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.00011	0.00109	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000109	0.00108	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000109	0.00108	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000101	0.000997	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.91e-05	0.000981	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	9.45e-05	0.000936	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	8.48e-05	0.00084	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.28e-05	0.00082	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	8.05e-05	0.000797	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	8e-05	0.000792	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—chronic obstructive pulmonary disease	7.72e-05	0.000765	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.7e-05	0.000762	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	7.64e-05	0.000757	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.63e-05	0.000756	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GC—chronic obstructive pulmonary disease	7.49e-05	0.000741	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.39e-05	0.000731	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.96e-05	0.000689	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.9e-05	0.000683	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.97e-05	0.000591	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.55e-05	0.000549	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	5.54e-05	0.000548	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	5.46e-05	0.000541	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	5.36e-05	0.000531	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	5.08e-05	0.000503	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.93e-05	0.000488	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.15e-05	0.000411	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.09e-05	0.000405	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	4.04e-05	0.0004	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.96e-05	0.000392	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.69e-05	0.000365	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.4e-05	0.000337	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.85e-05	0.000283	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.83e-05	0.000281	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.8e-05	0.000277	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.62e-05	0.000259	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.61e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000245	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	2.16e-05	0.000213	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.61e-05	0.000159	CbGpPWpGaD
